Australia's most trusted
source of pharma news
Thursday, 07 November 2024
Posted 4 November 2024 PM
In consultation with a neurologist, GPs can now prescribe three PBS listed migraine drugs - Teva Pharma's Ajovy, Eli Lilly's Emgality and Lundbeck's Vyepti - after a rule change came into effect this month.
As of 1 November, the condition on the PBS listing was changed from 'Must be treated by a neurologist' to 'Must be treated by a neurologist' or 'Must be treated by a general practitioner in consultation with a neurologist'.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.